CSPC Pharmaceutical Group Limited (01093) said its profit attributable to shareholders was RMB1.16 billion for the three months ended 31 March 2020, a year-on-year increase of 21.8%. The basic earnings per share were RMB18.59 cents. No dividend will be distributed.
The total revenue was RMB6.13 billion, a year-on-year increase of 11.5%.
27/05/2020 12:12
CSPC Pharma (01093) 3-month net up 21.8% to RMB1.16bn
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
